Related Experiment Video
Updated: Aug 16, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
Optimal microRNA Sequencing Depth to Predict Cancer Patient Survival with Random Forest and Cox Models
Rémy Jardillier1,2, Dzenis Koca1, Florent Chatelain2
1Univ. Grenoble Alpes, CEA, Inserm, IRIG, BioSanté U1292, BCI, 38000 Grenoble, France.
Optimizing cancer patient survival prediction involves balancing sequencing depth and patient numbers. Tumor profiling with RNA sequencing (RNA-seq) data, including microRNA (miRNA) and messenger RNA (mRNA), enhances prediction accuracy cost-effectively.
Area of Science:
- Oncology
- Bioinformatics
- Genomics
Background:
- Tumor profiling using RNA sequencing (RNA-seq) is crucial for predicting patient survival.
- Study design requires calibrating sequencing depth and patient cohort size under cost constraints.
- Balancing these parameters is essential for effective survival prediction models.
Purpose of the Study:
- To benchmark the impact of patient number and RNA-seq sequencing depth (miRNA-seq and mRNA-seq) on predictive capabilities.
- To compare the performance of the Cox model with elastic net penalty and random survival forest for survival prediction.
- To evaluate the contribution of miRNA and mRNA data, individually and combined, to prediction accuracy.
Main Methods:
- Comparative analysis of Cox model with elastic net penalty and random survival forest.
- Benchmarking predictive performance using varying numbers of patients and sequencing depths for miRNA-seq and mRNA-seq data.
- Assessment of prediction improvement over clinical data alone.
Main Results:
- Cox model and random survival forest showed comparable predictive capabilities, with cancer-specific variations.
- miRNA and/or mRNA data significantly improved prediction accuracy compared to clinical data alone.
- mRNA-seq generally outperformed miRNA-seq, except in lung adenocarcinoma where miRNA-seq was superior.
- Reduced sequencing depth maintained predictive ability for most cancers, enabling cost savings.
- Fewer patients in training datasets were sufficient for both models, allowing subgroup analysis.
Conclusions:
- RNA-seq data, particularly mRNA, enhances cancer survival prediction, with miRNA-seq being valuable for specific cancers like lung adenocarcinoma.
- Sequencing depth and patient numbers can be reduced without compromising predictive power, optimizing study costs.
- These findings facilitate the development of more cost-effective and accurate patient survival prediction strategies.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
Cancer Survival Analysis
MicroRNAs